Efficacy of Moderna, Pfizer and Johnson & Johnson COVID-19 Vaccines Against the Omicron Variant
Read synopses of how each vaccine fares against the Omicron variant according to the latest data:
Read More »
Johnson and Johnson
Adenovirus Vaccines and Blood Clots
New research suggests how COVID-19 adenovirus vaccines may lead to extremely rare cases of thrombosis with thrombocytopenia syndrome (TTS), an autoimmune response which can lead to fatal blood clots. Thrombosis with thrombocytopenia was verified by the WHO as a possible adverse event to AstraZeneca and Johnson & Johnson COVID-19 vaccines earlier this year, following the first but rarely after the second dose.
Read More »CDC expands eligibility of boosters for 18+
Last Friday, the CDC expanded booster eligibility for everyone over 18 years of age. Those who received a Pfizer or Moderna vaccine may now receive a booster dose 6 months after their primary series.
Read More »FDA Authorizes Pfizer and Moderna Boosters for 18+
This morning, the FDA expanded eligibility around booster shots of both the Pfizer and Moderna vaccines for adults 18+, six months after their primary series. Those who have received a Johnson & Johnson vaccine for their primary series can receive a Pfizer or Moderna booster dose two months after their single dose primary series
Read More »